tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Condulis, 30 are a BUY (93.75%), 2 are a HOLD (6.25%).
Analyst James Condulis, currently employed at STIFEL, carries an average stock price target met ratio of 29.44% that have a potential upside of 37.47% achieved within 102 days.
James Condulis’s has documented 61 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 15-Oct-2026.
Analyst best performing recommendations are on MIRM (MIRUM PHARMACEUTICALS).
The best stock recommendation documented was for SLNO (SOLENO THERAPEUTICS) at 3/12/2025. The price target of $74 was fulfilled within 43 days with a profit of $27.3 (58.46%) receiving and performance score of 13.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2014
$140
$78.77 (128.65%)
$140
Buy Since 08-Nov-2024
$113
$51.77 (84.55%)
$112
16 days ago
(08-Oct-2026)
4/11 (36.36%)
$50.99 (82.23%)
448
Buy Since 09-Dec-2022
$103
$41.77 (68.22%)
$97
2 months 11 days ago
(13-Aug-2026)
10/12 (83.33%)
$29.55 (40.23%)
312
Buy Since 20-Dec-2022
$112
$50.77 (82.92%)
$106
2 months 14 days ago
(10-Aug-2026)
6/9 (66.67%)
$34.51 (44.53%)
366
Buy Since 08-May-2017
$110
$48.77 (79.65%)
$96
2 months 17 days ago
(07-Aug-2026)
20/25 (80%)
$33.24 (43.30%)
406
Which stock is James Condulis most bullish on?
Which stock is James Condulis most reserved on?
What Year was the first public recommendation made by James Condulis?
